Metraipolis › archive › dc_036fb4a5c8d2

Advances in Tumor Antigen Vaccines: A New Frontier in Cancer Immunotherapy — Europe PMC PMID:41209563

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41209563
DOI
10.7150/ijms.120868
License (as archived)
solo-consultazione
Archived
2026-11-09T02:18:04.207Z
SHA-256 of the archived text
0376832bb84934c7262b572bb7f640d78e4f9446eb79b172d6675c3ac985ce09
Stable URL of this page
https://metraipolis.com/documento/dc_036fb4a5c8d2

How to cite

Advances in Tumor Antigen Vaccines: A New Frontier in Cancer Immunotherapy — Europe PMC PMID:41209563 — Europe PMC (en), https://europepmc.org/article/MED/41209563 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_036fb4a5c8d2 (Metraipolis archive dc_036fb4a5c8d2, sha256 0376832bb84934c7262b572bb7f640d78e4f9446eb79b172d6675c3ac985ce09)
BibTeX
@misc{dc036fb4a5c8d2,
  title = {Advances in Tumor Antigen Vaccines: A New Frontier in Cancer Immunotherapy — Europe PMC PMID:41209563},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41209563},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_036fb4a5c8d2; sha256 0376832bb84934c7262b572bb7f640d78e4f9446eb79b172d6675c3ac985ce09},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41209563. Agents can read the archived copy with the MCP tool read_document.